Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade

Molecular Carcinogenesis

Volumn 19, Issue 3, 1997, Pages 153-156

  Rogalla, Piere ^a   Drechsler, Klaus ^a   Kazmierczak, Bernd ^a   Rippe, Volkhard ^b   Bonk, Ulrich ^a   Bullerdiek, Jörn ^a,b  

^a UNIVERSITY OF BREMEN   (Germany)

^b Hospital Bremen East   (Germany)

Author keywords

High mobility group protein gene HMGI C expression; Histologic grade; Prognostic value; Tumor progression

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

ARTICLE; BREAST CANCER; CHROMOSOME 12P; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

ADULT; BLOTTING, NORTHERN; BREAST NEOPLASMS; FEMALE; HIGH MOBILITY GROUP PROTEINS; HMGA2 PROTEIN; HUMANS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030751533     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F     Document Type: Article

References (32)

1. Thanos D, Maniatis T. The high mobility group protein HMGI(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777-789, 1992.
2. Du W, Maniatis T. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. Proc Natl Acad Sci USA 91:11318-11322, 1994.
3. Saitoh Y, Laemmli UK. Metaphase chromosome structure: Bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76:609-622, 1994.
4. Tjian R, Maniatis T. Transcriptional activation: A complex puzzle with few easy pieces. Cell 77:5-8, 1994.
5. Falvo JV, Thanos D, Maniatis T. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83:1101-1111, 1995.
6. Schoenmakers EFPM, Mols R, Wanschura S, et al. Identification, molecular cloning and characterization of the chromosome breakpoint cluster region of uterine leiomyomas. Genes Chromosomes Cancer 11:106-118, 1994.
7. Van de Ven WJM, Schoenmakers EFPM, Wanschura S, et al. Molecular characterization of MAR, a multiple aberration region on human chromosome 12q13-15 implicated in various solid tumors. Genes Chromosomes Cancer 12:296-303, 1994.
8. Ashar HR, Schoenberg Fejzo M, Tkachenko A, et al. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65, 1995.
9. Kazmierczak B, Wanschura S, Rosigkeit J, et al. Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas. Cancer Res 55:2497-2499, 1995.
10. Kazmierczak B, Wanschura S, Meyer-Bolte K, et al. Cytogenetic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147:580-585, 1995.
11. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet 10:436-444, 1995.
12. Bol S, Wanschura S, Thode B, et al. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosome 2 and 12. Cancer Genet Cytogenet 90:88-90, 1996.
13. Kazmierczak B, Rosigkeit J, Wanschura S, et al. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: A survey of 30 tumors. Oncogene 12:515-521, 1996.
14. Rohen C, Caselitz J, Stern C, et al. A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet 84:82-84, 1995.
15. Staats B, Bonk U, Wanschura S, et al. A fibroadenoma with a t(4;12)(q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38:299-303, 1996.
16. Kazmierczak B, Hennig Y, Wanschura S, et al. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55:6038-6039, 1995.
17. Wanschura S, Kazmierczak B, Meyer-Bolte K, et al. Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality. Cancer Lett 102:17-21, 1996.
18. Rogalla P, Drechsler K, Frey G, et al. HMGI-C expression patterns in human tissues - Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775-779, 1996.
19. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774, 1995.
20. Dalton LW, Page DL, Dupont WD. Histologic grading of breast carcinoma. Cancer 73:2765-2770, 1994.
21. Giancotti V, Bandiera A, Buratti E, et al. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Eur J Biochem 198:211-216, 1991.
22. Chau K-Y, Patel UA, Lee K-KD, Lam H-YP, Crane-Robinson C. The gene for human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element. Nucleic Acids Res 23:4262-4266, 1995.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
24. Giancotti V, Berlingieri MT, DiFiore PP, Fusco A, Vecchio G, Crane-Robinson C. Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res 45:6051-6057, 1985.
25. Goodwin GH, Cockerill PN, Kellam S, Wright CA. Fractionation by high-performance liquid chromatography of the low-molecular-mass high-mobility-group (HMG) chromosomal proteins present in proliferating rat cells and an investigation of the HMG proteins present in virus transformed cells. Eur J Biochem 149:47-51, 1985.
26. Giancotti V, Pani B, Andrea PD, et al. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyom middle T genes. EMBO J 6:1981-1987, 1987.
27. Giancotti V, Buratti E, Perissin L, et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res 184:538-545, 1989.
28. Manfioletti G, Giancotti V, Bandiera A, et al. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 19:6793-6797, 1991.
29. Wanschura S, Kazmierczak B, Schoenmakers EFPM, et al. Regional fine mapping of the multiple aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Genes Chromosomes Cancer 14:68-70, 1995.
30. Tamimi Y, Van der Poel HG, Denyn MM, et al. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 53:5512-5516, 1993.
31. Chiappetta G, Bandiera A, Berlingieri MT, et al. The expression of the high mobility group HMGI(Y) protein correlates with the malignant phenotype of human thyroid neoplasms. Oncogene 10:1307-1314, 1995.
32. Fedele M, Bandiera A, Chiappetta G, et al. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 56:1896-1901, 1996.